Development of a cross-sectoral antimicrobial resistance capability assessment framework

dc.contributor.authorFerdinand, Angeline S.
dc.contributor.authorMcEwan, Callum
dc.contributor.authorLin, Chantel
dc.contributor.authorBetham, Kassandra
dc.contributor.authorKandan, Karishma
dc.contributor.authorTamolsaian, Gilam
dc.contributor.authorPugeva, Barry
dc.contributor.authorMcKenzie, Joanna
dc.contributor.authorBrowning, Glenn
dc.contributor.authorGilkerson, James
dc.contributor.authorCoppo, Mauricio
dc.contributor.authorJames, Rodney
dc.date.accessioned2024-11-14T19:43:04Z
dc.date.available2024-11-14T19:43:04Z
dc.date.issued2024-07
dc.descriptionIndexación: Scopus
dc.description.abstractAntimicrobial resistance (AMR) is an urgent and growing global health concern, and a clear understanding of existing capacities to address AMR, particularly in low-income and middle-income countries (LMICs), is needed to inform national priorities, investment targets and development activities. Across LMICs, there are limited data regarding existing mechanisms to address AMR, including national AMR policies, current infection prevention and antimicrobial prescribing practices, antimicrobial use in animals, and microbiological testing capacity for AMR. Despite the development of numerous individual tools designed to inform policy formulation and implementation or surveillance interventions to address AMR, there is an unmet need for easy-to-use instruments that together provide a detailed overview of AMR policy, practice and capacity. This paper describes the development of a framework comprising five assessment tools which provide a detailed assessment of country capacity to address AMR within both the human and animal health sectors. The framework is flexible to meet the needs of implementers, as tools can be used separately to assess the capacity of individual institutions or as a whole to align priority-setting and capacity-building with AMR National Action Plans (NAPs) or national policies. Development of the tools was conducted by a multidisciplinary team across three phases: (1) review of existing tools; (2) adaptation of existing tools; and (3) piloting, refinement and finalisation. The framework may be best used by projects which aim to build capacity and foster cross-sectoral collaborations towards the surveillance of AMR, and by LMICs wishing to conduct their own assessments to better understand capacity and capabilities to inform future investments or the implementation of NAPs for AMR.
dc.identifier.citationBMJ Global Health Volume 9, Issue 1 16 January 2024 Article number e013280
dc.identifier.doi10.1136/bmjgh-2023-013280
dc.identifier.issn2059-7908
dc.identifier.urihttps://repositorio.unab.cl/handle/ria/62013
dc.language.isoen
dc.publisherBMJ Publishing Group
dc.rights.licenseAttribution-NonCommercial 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subjectHealth systems evaluation
dc.subjectInfections
dc.subjectdiseases
dc.subjectdisorders
dc.subjectinjuries
dc.subjectMedical microbiology
dc.subjectPublic Health
dc.titleDevelopment of a cross-sectoral antimicrobial resistance capability assessment framework
dc.typeArtículo
Archivos
Bloque original
Mostrando 1 - 2 de 2
No hay miniatura disponible
Nombre:
Angeline S Ferdinand_Development of a cross-sectoral_2024.pdf
Tamaño:
327.91 KB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLES
No hay miniatura disponible
Nombre:
Angeline S Ferdinand_Development of a cross-sectoral_2024Anexo.pdf
Tamaño:
152.13 KB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLES
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción: